SKORVANEK, M., J.G. GOLDMAN, M. JAHANSHAHI, C. MARRAS, Irena REKTOROVÁ, B. SCHMAND, E. VAN DUIJN, C.G. GOETZ, D. WEINTRAUB, G.T. STEBBINS and P. MARTINEZ-MARTIN. Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations. Movement Disorders. Hoboken: Wiley-Blackwell, 2018, vol. 33, No 2, p. 208-218. ISSN 0885-3185. Available from: https://dx.doi.org/10.1002/mds.27233.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Global Scales for Cognitive Screening in Parkinson's Disease: Critique and Recommendations
Authors SKORVANEK, M. (703 Slovakia), J.G. GOLDMAN (276 Germany), M. JAHANSHAHI (826 United Kingdom of Great Britain and Northern Ireland), C. MARRAS (124 Canada), Irena REKTOROVÁ (203 Czech Republic, guarantor, belonging to the institution), B. SCHMAND (528 Netherlands), E. VAN DUIJN (528 Netherlands), C.G. GOETZ (840 United States of America), D. WEINTRAUB (840 United States of America), G.T. STEBBINS (840 United States of America) and P. MARTINEZ-MARTIN (724 Spain).
Edition Movement Disorders, Hoboken, Wiley-Blackwell, 2018, 0885-3185.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30103 Neurosciences
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 8.222
RIV identification code RIV/00216224:14740/18:00106658
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1002/mds.27233
UT WoS 000424815100005
Keywords in English Parkinson's disease; cognitive; dementia; rating scales; clinimetric
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 19/3/2019 15:10.
Abstract
Background: Cognitive impairment is a common nonmotor manifestation of Parkinson's disease, with deficits ranging from mild cognitive difficulties in 1 or more of the cognitive domains to severe dementia. The International Parkinson and Movement Disorder Society commissioned the assessment of the clinimetric properties of cognitive rating scales measuring global cognitive performance in PD to make recommendations regarding their use. Methods: A systematic literature search was conducted to identify the scales used to assess global cognitive performance in PD, and the identified scales were reviewed and rated as "recommended," "recommended with caveats," "suggested," or "listed" by the panel using previously established criteria. Results: A total of 12 cognitive scales were included in this review. Three scales, the Montreal Cognitive Assessment, the Mattis Dementia Rating Scale Second Edition, and the Parkinson's Disease-Cognitive Rating Scale, were classified as "recommended." Two scales were classified as "recommended with caveats": the Mini-Mental Parkinson, because of limited coverage of executive abilities, and the Scales for Outcomes in Parkinson's Disease-Cognition, which has limited data on sensitivity to change. Six other scales were classified as "suggested" and 1 scale as "listed." Conclusions: Because of the existence of "recommended" scales for assessment of global cognitive performance in PD, this task force suggests that the development of a new scale for this purpose is not needed at this time. However, global cognitive scales are not a substitute for comprehensive neuropsychological testing. (C) 2017 International Parkinson and Movement Disorder Society
PrintDisplayed: 27/7/2024 13:49